Prostate cancer risk is not altered by TP53AIP1 germline mutations in a German case-control series.
Luedeke M, Coinac I, Linnert CM, Bogdanova N, Rinckleb AE, Schrader M, Vogel W, Hoegel J, Meyer A, Dörk T, et al. PLoS One. 2012; 7(3):e34128. Epub 2012 Mar 23.